Skip to main content

Iridex Corp

IRIX
Exchange
Nasdaq
Industry
Electromedical & Electrotherapeutic Apparatus
SEC CIK
0001006045

In the last 90 days, Iridex Corp insiders filed 4 open-market purchases and 0 sales; 29 institutions reported holding it in 13F filings for Q2 2026, worth $2.47M in total; no superinvestor holds it.

Q1 2023 vs. Q4 2022

How the institutions holding Iridex Corp changed between Q4 2022 and Q1 2023.

All holders in Q1 2023All holders in Q4 2022

13F holders of IRIX: Q4 2022 compared with Q1 2023
MeasureQ4 2022Q1 2023Change
Holders2631+5
Shares3.60M3.70M+108.7K (+3.0%)
Value$7.23M$7.56M+$327.4K (+4.5%)

New holders (7)

Institutions that held Iridex Corp at the end of Q1 2023 but not at the end of Q4 2022.

Institutions new to IRIX in Q1 2023
InstitutionSharesValue% of portfolio
Clayton Partners LLC28,793$58.5K0.06%
AMH Equity Ltd27,040$54.9K0.07%
Susquehanna International Group, LLP10,094$21.0K0.00%
Pointe Capital Management LLC3,235$6.57K0.00%
UBS Group AG2,816$5.72K0.00%
Venturi Wealth Management, LLC750$1.52K0.00%
Tower Research Capital LLC (TRC)114$00.00%

Sold out (2)

Institutions that held Iridex Corp at the end of Q4 2022 and filed for Q1 2023 without it.

Institutions that sold out of IRIX in Q1 2023
InstitutionShares, Q4 2022Value, Q4 2022
Truvestments Capital LLC562$1.13K
Bank of America Corp15$30